Effect of Lidocaine in Reducing Opioids Requirement in Day Care Surgery
NCT ID: NCT06717672
Last Updated: 2024-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
80 participants
INTERVENTIONAL
2023-11-05
2024-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. \*Decreased pain scores
3. \*Fewer opioid-related side effects
4. \*Improved patient satisfaction
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period.
By reducing opioid consumption, lidocaine can also decrease the incidence of opioid-related side effects, such as nausea, vomiting, and respiratory depression.
Lidocaine's analgesic effects can improve patient satisfaction and reduce anxiety related to pain
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
intervention group recieve inj lidocaine
Lidocaine 2% without vessel constrictor
1. \_Lidocaine 2% provides rapid and effective local anesthesia for minor surgical procedures, such as biopsies, excisions, and suturing.
2. \_Pain relief\_: Lidocaine 2% has been shown to provide significant pain relief in patients with acute pain, such as post-operative pain, trauma, and burns.
3. \_Reducing pain intensity\_: Lidocaine 2% has been shown to reduce pain intensity by 30-50% in various clinical studies.
Control group
control group receive Normal saline
Normal Saline
Normal saline used is an iv fluid given for fluid replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine 2% without vessel constrictor
1. \_Lidocaine 2% provides rapid and effective local anesthesia for minor surgical procedures, such as biopsies, excisions, and suturing.
2. \_Pain relief\_: Lidocaine 2% has been shown to provide significant pain relief in patients with acute pain, such as post-operative pain, trauma, and burns.
3. \_Reducing pain intensity\_: Lidocaine 2% has been shown to reduce pain intensity by 30-50% in various clinical studies.
Normal Saline
Normal saline used is an iv fluid given for fluid replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient age between 18 and 65 years
* Patient undergoing ambulatory surgeries
Exclusion Criteria
* Allergic to Lidocaine Patient who had fever and treated with antibiotic and steroid in last month
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liaquat National Hospital & Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanesh Tanwani
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanesh Tanwani Dr Hanesh Tanwani
Role: PRINCIPAL_INVESTIGATOR
Liaquat National Hospital and Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liaquat National Hospital and Medical College
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery Allannah McKay 1, Antje Gottschalk, Annette Ploppa, Marcel E Durieux, Danja S Groves
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANS-2021-192-2750
Identifier Type: -
Identifier Source: org_study_id